| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B DNAH3 MYH9 SMARCA5 ABCA2 DNAH10 MYO7A ABCA13 KIF26B UBA2 SMARCAD1 SMC5 KIF7 MDN1 MOV10L1 SHPRH ABCD4 MACF1 ABCD2 DNAH5 DNAH8 HSPA4 DYNC1H1 | 1.13e-09 | 614 | 163 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | KIF13B DNAH3 MYH9 DNAH10 MYO7A KIF26B KIF7 DNAH5 DNAH8 DYNC1H1 | 4.55e-08 | 118 | 163 | 10 | GO:0003774 |
| GeneOntologyMolecularFunction | kinase binding | KIF13B MYH9 WWC3 DSCAM DSP PPP1R9A PTPN23 TNS2 RFFL TRIM64 PFKL LCK PRC1 ITGAV NOD2 TRIM64B NEFH KCNH1 PIK3R1 PIK3R2 PKD1 SPDYE3 PRMT1 IGSF9B WWC1 EPHA1 | 8.41e-08 | 969 | 163 | 26 | GO:0019900 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.02e-07 | 70 | 163 | 8 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B DNAH3 SMARCA5 ABCA2 DNAH10 ABCA13 SMARCAD1 SMC5 KIF7 MDN1 MOV10L1 ABCD4 MACF1 ABCD2 DNAH5 DNAH8 DYNC1H1 | 1.30e-07 | 441 | 163 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.68e-07 | 18 | 163 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein kinase binding | KIF13B MYH9 DSCAM DSP PPP1R9A PTPN23 TNS2 RFFL TRIM64 LCK PRC1 ITGAV NOD2 TRIM64B NEFH KCNH1 PIK3R1 PIK3R2 PKD1 SPDYE3 PRMT1 EPHA1 | 2.60e-06 | 873 | 163 | 22 | GO:0019901 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.88e-06 | 28 | 163 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.20e-05 | 37 | 163 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRP GABRQ PKD1L2 ITGAV CHRNA2 PANX3 CHRNA3 CHRNB2 ANO8 KCNE4 KCNH1 PKD1 TMC5 | 1.04e-04 | 459 | 163 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | arginine N-methyltransferase activity | 1.11e-04 | 12 | 163 | 3 | GO:0016273 | |
| GeneOntologyMolecularFunction | protein-arginine N-methyltransferase activity | 1.11e-04 | 12 | 163 | 3 | GO:0016274 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.90e-04 | 65 | 163 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.90e-04 | 65 | 163 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B DNAH3 SMARCA5 ABCA2 DNAH10 ABCA13 SMARCAD1 SMC5 KIF7 MDN1 MOV10L1 ABCD4 MACF1 ABCD2 DNAH5 DNAH8 DYNC1H1 | 2.08e-04 | 775 | 163 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 3.34e-04 | 17 | 163 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | channel activity | GABRP GABRQ PKD1L2 ITGAV CHRNA2 PANX3 CHRNA3 CHRNB2 ANO8 KCNE4 KCNH1 PKD1 TMC5 | 3.86e-04 | 525 | 163 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRP GABRQ PKD1L2 ITGAV CHRNA2 PANX3 CHRNA3 CHRNB2 ANO8 KCNE4 KCNH1 PKD1 TMC5 | 3.93e-04 | 526 | 163 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.19e-04 | 77 | 163 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRP GABRQ ITGAV CHRNA2 CHRNA3 CHRNB2 ANO8 KCNE4 KCNH1 TMC5 | 4.32e-04 | 334 | 163 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF13B DNAH3 SMARCA5 ABCA2 DNAH10 ABCA13 SMARCAD1 SMC5 KIF7 MDN1 MOV10L1 ABCD4 MACF1 ABCD2 DNAH5 DNAH8 DYNC1H1 | 5.18e-04 | 839 | 163 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF13B DNAH3 SMARCA5 ABCA2 DNAH10 ABCA13 SMARCAD1 SMC5 KIF7 MDN1 MOV10L1 ABCD4 MACF1 ABCD2 DNAH5 DNAH8 DYNC1H1 | 5.25e-04 | 840 | 163 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF13B DNAH3 SMARCA5 ABCA2 DNAH10 ABCA13 SMARCAD1 SMC5 KIF7 MDN1 MOV10L1 ABCD4 MACF1 ABCD2 DNAH5 DNAH8 DYNC1H1 | 5.25e-04 | 840 | 163 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.81e-04 | 49 | 163 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 8.39e-04 | 23 | 163 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | microtubule binding | 9.90e-04 | 308 | 163 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 1.35e-03 | 27 | 163 | 3 | GO:0017134 | |
| GeneOntologyMolecularFunction | protein-arginine omega-N asymmetric methyltransferase activity | 1.35e-03 | 7 | 163 | 2 | GO:0035242 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.38e-03 | 100 | 163 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B VPS18 MYH9 PDE4B MYO7A KIF26B SYNE1 PPP1R9A PRC1 LCP1 KIF7 NOD2 NEFH LMOD3 TUBGCP3 MACF1 AFDN CEP295 MTCL1 | 1.62e-03 | 1099 | 163 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | acyltransferase activity | TRAF3IP2 VPS18 NAA15 RNF19A WWP2 AGPAT2 FBXO11 RFFL TRIM64 SAT2 TRIM64B KLHL9 BRPF1 SHPRH NAA40 | 1.74e-03 | 775 | 163 | 15 | GO:0016746 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.08e-03 | 343 | 163 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.67e-03 | 227 | 163 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | tubulin binding | KIF13B PDE4B KIF26B PRC1 KIF7 NEFH TUBGCP3 MACF1 CEP295 MTCL1 | 2.77e-03 | 428 | 163 | 10 | GO:0015631 |
| GeneOntologyMolecularFunction | G-quadruplex RNA binding | 2.85e-03 | 10 | 163 | 2 | GO:0002151 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF13B DNAH3 MYH9 DNAH10 RNF19A KIF26B RANBP9 ODAD4 PRC1 ADCY3 KIF7 CCNF NEFH CEP120 TUBGCP3 PKD1 MAP7D2 MACF1 CEP295 MTCL1 DNAH5 DNAH8 DYNC1H1 CFAP46 | 2.47e-06 | 1058 | 161 | 24 | GO:0007017 |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B NES DNAH3 VPS18 MYH9 PDE4B DNAH10 DSP KIF26B SYNE1 PRC1 LCP1 KIF7 NEFH LMOD3 RTL1 TUBGCP3 IFFO2 MACF1 CEP295 MTCL1 DNAH5 DNAH8 DYNC1H1 | 1.52e-05 | 1179 | 163 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B NES DNAH3 VPS18 MYH9 PDE4B DNAH10 DSP KIF26B SYNE1 PRC1 LCP1 KIF7 NEFH LMOD3 RTL1 TUBGCP3 IFFO2 MACF1 CEP295 MTCL1 DNAH5 DNAH8 DYNC1H1 | 1.70e-05 | 1187 | 163 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF13B NES DNAH3 VPS18 MYH9 DNAH10 DSP KIF26B PRC1 LCP1 KIF7 NEFH TUBGCP3 IFFO2 MACF1 CEP295 MTCL1 DNAH5 DNAH8 DYNC1H1 | 2.42e-05 | 899 | 163 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule associated complex | 3.93e-05 | 161 | 163 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.97e-05 | 25 | 163 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 6.30e-05 | 54 | 163 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule | KIF13B DNAH3 DNAH10 KIF26B PRC1 KIF7 TUBGCP3 MACF1 CEP295 MTCL1 DNAH5 DNAH8 DYNC1H1 | 2.89e-04 | 533 | 163 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 3.48e-04 | 18 | 163 | 3 | GO:0000159 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 3.48e-04 | 18 | 163 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | microtubule organizing center | ABCA2 PDE4B RNF19A RANBP9 PTPN23 CCDC178 LCK KIF7 CCNF TTC8 CEP120 GLG1 TUBGCP3 CEP295 NAA40 AGBL2 DYNC1H1 | 8.60e-04 | 919 | 163 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | 9+0 motile cilium | 8.88e-04 | 6 | 163 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 8.88e-04 | 6 | 163 | 2 | GO:0043190 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.22e-03 | 332 | 163 | 9 | GO:0005788 | |
| Domain | ATPase_dyneun-rel_AAA | 1.06e-09 | 14 | 161 | 6 | IPR011704 | |
| Domain | AAA_5 | 1.06e-09 | 14 | 161 | 6 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.41e-08 | 14 | 161 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 8.41e-08 | 14 | 161 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 8.41e-08 | 14 | 161 | 5 | IPR013602 | |
| Domain | DHC_N2 | 8.41e-08 | 14 | 161 | 5 | PF08393 | |
| Domain | MT | 8.41e-08 | 14 | 161 | 5 | PF12777 | |
| Domain | AAA_8 | 8.41e-08 | 14 | 161 | 5 | PF12780 | |
| Domain | DHC_fam | 1.25e-07 | 15 | 161 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 1.25e-07 | 15 | 161 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.25e-07 | 15 | 161 | 5 | IPR004273 | |
| Domain | DHC_N1 | 3.62e-07 | 8 | 161 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.62e-07 | 8 | 161 | 4 | IPR013594 | |
| Domain | AAA | DNAH3 ABCA2 DNAH10 ABCA13 MDN1 ABCD4 ABCD2 DNAH5 DNAH8 DYNC1H1 | 4.88e-07 | 144 | 161 | 10 | SM00382 |
| Domain | AAA+_ATPase | DNAH3 ABCA2 DNAH10 ABCA13 MDN1 ABCD4 ABCD2 DNAH5 DNAH8 DYNC1H1 | 4.88e-07 | 144 | 161 | 10 | IPR003593 |
| Domain | P-loop_NTPase | KIF13B DNAH3 MYH9 SMARCA5 ABCA2 DNAH10 MYO7A ABCA13 KIF26B NDST4 SMARCAD1 SMC5 KIF7 NOD2 MDN1 MOV10L1 YLPM1 SHPRH ABCD4 ABCD2 DNAH5 DNAH8 DYNC1H1 | 1.07e-06 | 848 | 161 | 23 | IPR027417 |
| Domain | - | DNAH3 SMARCA5 ABCA2 DNAH10 MYO7A ABCA13 NDST4 SMARCAD1 SMC5 NOD2 MDN1 MOV10L1 YLPM1 SHPRH ABCD4 ABCD2 DNAH5 DNAH8 DYNC1H1 | 2.40e-05 | 746 | 161 | 19 | 3.40.50.300 |
| Domain | Neurotransmitter_ion_chnl_CS | 4.14e-05 | 45 | 161 | 5 | IPR018000 | |
| Domain | Neur_chan_memb | 4.61e-05 | 46 | 161 | 5 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 5.12e-05 | 47 | 161 | 5 | IPR006029 | |
| Domain | - | 5.12e-05 | 47 | 161 | 5 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 5.12e-05 | 47 | 161 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 5.12e-05 | 47 | 161 | 5 | PS00236 | |
| Domain | Neur_channel | 5.12e-05 | 47 | 161 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 5.12e-05 | 47 | 161 | 5 | IPR006202 | |
| Domain | MAP65_Ase1_PRC1 | 7.39e-05 | 2 | 161 | 2 | IPR007145 | |
| Domain | Osteonectin_CS | 7.39e-05 | 2 | 161 | 2 | IPR001999 | |
| Domain | OSTEONECTIN_1 | 7.39e-05 | 2 | 161 | 2 | PS00612 | |
| Domain | OSTEONECTIN_2 | 7.39e-05 | 2 | 161 | 2 | PS00613 | |
| Domain | TPR-like_helical_dom | 1.94e-04 | 233 | 161 | 9 | IPR011990 | |
| Domain | PI3K_P85_iSH2 | 2.20e-04 | 3 | 161 | 2 | IPR032498 | |
| Domain | PI3K_P85_iSH2 | 2.20e-04 | 3 | 161 | 2 | PF16454 | |
| Domain | Nicotinic_acetylcholine_rcpt | 3.24e-04 | 16 | 161 | 3 | IPR002394 | |
| Domain | PP2A_PR55_CS | 4.38e-04 | 4 | 161 | 2 | IPR018067 | |
| Domain | PP2A_PR55 | 4.38e-04 | 4 | 161 | 2 | IPR000009 | |
| Domain | ABC_membrane_2 | 4.38e-04 | 4 | 161 | 2 | PF06472 | |
| Domain | REJ | 4.38e-04 | 4 | 161 | 2 | PS51111 | |
| Domain | REJ_dom | 4.38e-04 | 4 | 161 | 2 | IPR014010 | |
| Domain | PR55_2 | 4.38e-04 | 4 | 161 | 2 | PS01025 | |
| Domain | PR55_1 | 4.38e-04 | 4 | 161 | 2 | PS01024 | |
| Domain | - | 4.39e-04 | 207 | 161 | 8 | 1.25.40.10 | |
| Domain | FOLN | 7.26e-04 | 5 | 161 | 2 | PF09289 | |
| Domain | PI3kinase_P85 | 7.26e-04 | 5 | 161 | 2 | IPR001720 | |
| Domain | Follistatin/Osteonectin_EGF | 7.26e-04 | 5 | 161 | 2 | IPR015369 | |
| Domain | ABC_tran | 7.70e-04 | 48 | 161 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.70e-04 | 48 | 161 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 8.33e-04 | 49 | 161 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 9.00e-04 | 50 | 161 | 4 | IPR003439 | |
| Domain | - | 9.81e-04 | 23 | 161 | 3 | 1.20.120.370 | |
| Domain | ACTININ_2 | 9.81e-04 | 23 | 161 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.81e-04 | 23 | 161 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.81e-04 | 23 | 161 | 3 | IPR001589 | |
| Domain | Acetylcholine_rcpt_TM | 9.81e-04 | 23 | 161 | 3 | IPR027361 | |
| Domain | - | 1.08e-03 | 6 | 161 | 2 | 3.90.1290.10 | |
| Domain | PKD/REJ-like | 1.08e-03 | 6 | 161 | 2 | IPR002859 | |
| Domain | REJ | 1.08e-03 | 6 | 161 | 2 | PF02010 | |
| Domain | SANT_dom | 1.41e-03 | 26 | 161 | 3 | IPR017884 | |
| Domain | Plectin | 1.51e-03 | 7 | 161 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.51e-03 | 7 | 161 | 2 | IPR001101 | |
| Domain | PLEC | 1.51e-03 | 7 | 161 | 2 | SM00250 | |
| Domain | SANT | 1.76e-03 | 28 | 161 | 3 | PS51293 | |
| Domain | Spectrin_repeat | 1.95e-03 | 29 | 161 | 3 | IPR002017 | |
| Domain | SPARC/Testican_Ca-bd-dom | 2.00e-03 | 8 | 161 | 2 | IPR019577 | |
| Domain | SPARC_Ca_bdg | 2.00e-03 | 8 | 161 | 2 | PF10591 | |
| Domain | SAM_MT_PRMT | 2.55e-03 | 9 | 161 | 2 | PS51678 | |
| Domain | Arg_MeTrfase | 2.55e-03 | 9 | 161 | 2 | IPR025799 | |
| Domain | SNF2_N | 2.60e-03 | 32 | 161 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.60e-03 | 32 | 161 | 3 | PF00176 | |
| Domain | SPEC | 2.60e-03 | 32 | 161 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.60e-03 | 32 | 161 | 3 | IPR018159 | |
| Domain | TPR_REGION | 3.10e-03 | 165 | 161 | 6 | PS50293 | |
| Domain | TPR | 3.10e-03 | 165 | 161 | 6 | PS50005 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.50e-05 | 9 | 125 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.50e-05 | 9 | 125 | 3 | MM15313 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 8.83e-05 | 27 | 125 | 4 | M47755 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.07e-04 | 11 | 125 | 3 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.41e-04 | 12 | 125 | 3 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.41e-04 | 12 | 125 | 3 | MM15312 | |
| Pubmed | 4.37e-09 | 14 | 165 | 5 | 9373155 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KIF13B MYH9 ANKFY1 POLR1A NRDC PPP1R9A RANBP9 SRP68 FBXO11 PFKL KIF7 USP21 PPP2R1B KLHL9 TUBGCP3 YLPM1 SHPRH MRPL40 MTCL1 ZRANB1 TARBP1 | 1.45e-08 | 1005 | 165 | 21 | 19615732 |
| Pubmed | NES MYH9 SMARCA5 NAA15 POLR1A DSP SRP68 LCP1 MDN1 SUPT5H YLPM1 XRN1 SMARCC2 MACF1 AFDN HSPA4 DYNC1H1 | 1.66e-08 | 653 | 165 | 17 | 22586326 | |
| Pubmed | KIF13B NES MYH9 PDE4B ANKFY1 DSCAM SYNE1 PPP1R9A RANBP9 KIF7 NEFH NCOR2 MDN1 YLPM1 SMARCC2 MACF1 PRMT1 AFDN MTCL1 DYNC1H1 | 3.64e-08 | 963 | 165 | 20 | 28671696 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES ELOA CWF19L2 MYH9 SMARCA5 DSP SYNE1 AGPAT2 SRP68 FBXO11 SDAD1 WTAP SUPT5H TUBGCP3 YLPM1 SMARCC2 MACF1 PRMT1 MRPL40 NAA40 DYNC1H1 | 5.09e-08 | 1082 | 165 | 21 | 38697112 |
| Pubmed | 6.04e-08 | 9 | 165 | 4 | 12470648 | ||
| Pubmed | Tyrosine phosphorylation induced by C4 peptide constructs from HIV Gp120. | 4.18e-07 | 4 | 165 | 3 | 10422873 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 9123823 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES MYH9 SMARCA5 ANKFY1 NAA15 POLR1A DSP RANBP9 SRP68 PTPN23 SMARCAD1 PFKL NCOR2 MDN1 TUBGCP3 XRN1 SMARCC2 MACF1 PRMT1 AFDN HSPA4 DYNC1H1 | 4.98e-07 | 1353 | 165 | 22 | 29467282 |
| Pubmed | 6.76e-07 | 151 | 165 | 8 | 17043677 | ||
| Pubmed | 7.57e-07 | 36 | 165 | 5 | 22422068 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MYH9 SMARCA5 DSP SRP68 SMARCAD1 NCOR2 PPP2R1B MDN1 TUBGCP3 YLPM1 SMARCC2 MACF1 MTCL1 DYNC1H1 | 8.26e-07 | 582 | 165 | 14 | 20467437 |
| Pubmed | 1.11e-06 | 17 | 165 | 4 | 20395553 | ||
| Pubmed | 1.95e-06 | 234 | 165 | 9 | 36243803 | ||
| Pubmed | 2.08e-06 | 6 | 165 | 3 | 10095079 | ||
| Pubmed | 2.08e-06 | 6 | 165 | 3 | 10358157 | ||
| Pubmed | ANKFY1 PLVAP MYO7A SRP68 COLGALT2 ZNF442 KIF7 NCOR2 PPP2R2B MDN1 SMARCC2 CEP295 MTCL1 TARBP1 | 2.41e-06 | 638 | 165 | 14 | 31182584 | |
| Pubmed | ELOA SMARCA5 NRDC VPS50 RANBP9 UBA2 SDAD1 CEP120 SUPT5H GLG1 TUBGCP3 AFDN DYNC1H1 | 3.05e-06 | 560 | 165 | 13 | 35241646 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 9256245 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 9178760 | ||
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 3.62e-06 | 7 | 165 | 3 | 1505988 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 SMARCA5 NAA15 NRDC DSP PPFIBP1 RANBP9 SRP68 PTPN23 SMARCAD1 PFKL CPS1 GLG1 SMARCC2 MACF1 PRMT1 MTCL1 ADI1 HSPA4 TARBP1 DYNC1H1 | 3.88e-06 | 1415 | 165 | 21 | 28515276 |
| Pubmed | ANKFY1 SYNE1 PPP1R9A SMARCAD1 SMC5 ADCY3 NEFH MACF1 PPIP5K1 MTCL1 DYNC1H1 | 4.33e-06 | 407 | 165 | 11 | 12693553 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TRAF3IP2 KIF13B ELOA MYO7A PPFIBP1 VPS50 AGPAT2 RANBP9 SRP68 ITGAV KIF7 USP21 TTC8 CEP120 SUPT5H PIK3R1 EXOC6B PRMT1 AFDN DYNC1H1 | 5.01e-06 | 1321 | 165 | 20 | 27173435 |
| Pubmed | Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A. | 5.77e-06 | 8 | 165 | 3 | 12912990 | |
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 7.87e-06 | 27 | 165 | 4 | 18649358 | |
| Pubmed | VPS18 MYH9 SMARCA5 WWC3 WFS1 WWP2 RANBP9 SRP68 FBXO11 PFKL WTAP NCOR2 PIK3R1 PIK3R2 XRN1 SMARCC2 HSPA4 DYNC1H1 WWC1 | 8.04e-06 | 1247 | 165 | 19 | 27684187 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES SMARCA5 POLR1A DSP SYNE1 PPP1R9A PFKL KIF7 MDN1 SUPT5H YLPM1 SMARCC2 MACF1 PRMT1 AFDN HSPA4 DYNC1H1 | 8.29e-06 | 1024 | 165 | 17 | 24711643 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 8.45e-06 | 212 | 165 | 8 | 33853758 | |
| Pubmed | Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain. | 8.63e-06 | 9 | 165 | 3 | 17925405 | |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 8906617 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 15536084 | ||
| Pubmed | 9.04e-06 | 214 | 165 | 8 | 22199357 | ||
| Pubmed | 9.41e-06 | 360 | 165 | 10 | 33111431 | ||
| Pubmed | 1.02e-05 | 103 | 165 | 6 | 10574462 | ||
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 1.14e-05 | 105 | 165 | 6 | 19156129 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 MYH9 MYO7A DSP KIF26B SRP68 PFKL MDN1 PKD1 CCDC87 CEP295 IGSF9B MTCL1 DYNC1H1 | 1.22e-05 | 736 | 165 | 14 | 29676528 |
| Pubmed | ABCA2 DSCAM DSP PPFIBP1 SYNE1 RANBP9 FBXO11 SMARCAD1 SUPT5H PIK3R1 SCG2 YLPM1 PKD1 PRMT2 MACF1 AFDN SPARCL1 TARBP1 DYNC1H1 | 1.22e-05 | 1285 | 165 | 19 | 35914814 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 21203488 | ||
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 20736995 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DSP PPFIBP1 PTPN23 LCP1 KIF7 KLHL9 CEP120 BRPF1 PDCL3 XRN1 IFFO2 MAP7D2 AFDN CEP295 DYNC1H1 | 1.49e-05 | 853 | 165 | 15 | 28718761 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 SMARCA5 ANKFY1 POLR1A NRDC DNAH10 DSP SYNE1 SRP68 SMARCAD1 PFKL PRC1 SDAD1 MDN1 SUPT5H PRMT1 AFDN DNAH5 HSPA4 DYNC1H1 | 1.51e-05 | 1425 | 165 | 20 | 30948266 |
| Pubmed | NES VPS18 MYH9 NRDC MYO7A DSP WFS1 SYNE1 PPP1R9A SRP68 PFKL NEFH PPP2R2C XRN1 MAP7D2 SMARCC2 MACF1 AFDN HSPA4 DYNC1H1 | 1.60e-05 | 1431 | 165 | 20 | 37142655 | |
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 12225896 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 15117958 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 22173850 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 31577226 | ||
| Pubmed | Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL. | 1.68e-05 | 11 | 165 | 3 | 34831026 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.86e-05 | 171 | 165 | 7 | 20201926 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | SYNE1 PPP1R9A PTPN23 TNS2 PFKL PPP2R1B PPP2R2B PPP2R2C YLPM1 MTCL1 HSPA4 DYNC1H1 | 2.05e-05 | 573 | 165 | 12 | 28330616 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ELOA SMARCA5 DSP UBA2 RFFL SMARCAD1 WTAP QSOX1 NCOR2 MDN1 BRPF1 YLPM1 SMARCC2 AFDN | 2.13e-05 | 774 | 165 | 14 | 15302935 |
| Pubmed | 2.24e-05 | 12 | 165 | 3 | 10208934 | ||
| Pubmed | 2.24e-05 | 12 | 165 | 3 | 9341793 | ||
| Pubmed | Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. | 2.24e-05 | 2 | 165 | 2 | 16227599 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23221569 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16239435 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23077605 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32281240 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17164340 | ||
| Pubmed | Altered Anterior Segment Biometric Parameters in Mice Deficient in SPARC. | 2.24e-05 | 2 | 165 | 2 | 28122087 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9921897 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15743803 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 37863263 | ||
| Pubmed | Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. | 2.24e-05 | 2 | 165 | 2 | 17071741 | |
| Pubmed | Cloning and expression of murine SC1, a gene product homologous to SPARC. | 2.24e-05 | 2 | 165 | 2 | 9199668 | |
| Pubmed | Interplay between hevin, SPARC, and MDGAs: Modulators of neurexin-neuroligin transsynaptic bridges. | 2.24e-05 | 2 | 165 | 2 | 33535026 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9545638 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10459020 | ||
| Pubmed | Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. | 2.24e-05 | 2 | 165 | 2 | 15767666 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9461588 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21287502 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21851090 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 1314371 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32895527 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 33493647 | ||
| Pubmed | The exon structure of the mouse Sc1 gene is very similar to the mouse Sparc gene. | 2.24e-05 | 2 | 165 | 2 | 8938431 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16679292 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16679293 | ||
| Pubmed | Recent ultra-rare inherited variants implicate new autism candidate risk genes. | 2.24e-05 | 2 | 165 | 2 | 34312540 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21109194 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15681842 | ||
| Pubmed | Modulation of SPARC/Hevin Proteins in Alzheimer's Disease Brain Injury. | 2.24e-05 | 2 | 165 | 2 | 30883351 | |
| Pubmed | Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors. | 2.24e-05 | 2 | 165 | 2 | 35395865 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18534979 | ||
| Pubmed | Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. | 2.24e-05 | 2 | 165 | 2 | 21788491 | |
| Pubmed | Automated, computerized, feature-based phenotype analysis of slit lamp images of the mouse lens. | 2.24e-05 | 2 | 165 | 2 | 18304532 | |
| Pubmed | Sympathetic α₃β₂-nAChRs mediate cerebral neurogenic nitrergic vasodilation in the swine. | 2.24e-05 | 2 | 165 | 2 | 21536845 | |
| Pubmed | GSK3- and PRMT-1-dependent modifications of desmoplakin control desmoplakin-cytoskeleton dynamics. | 2.24e-05 | 2 | 165 | 2 | 25733715 | |
| Pubmed | NPR1 WWP2 RANBP9 PFKL NCOR2 SUPT5H YLPM1 PKD1 MACF1 AFDN SPARCL1 DYNC1H1 | 2.78e-05 | 591 | 165 | 12 | 15231748 | |
| Pubmed | 3.67e-05 | 14 | 165 | 3 | 19059502 | ||
| Pubmed | 3.67e-05 | 14 | 165 | 3 | 9400615 | ||
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 3.67e-05 | 14 | 165 | 3 | 9013886 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NPR1 NAA15 SYNE1 LCK CPS1 PRC1 SMC5 PPP2R1B CEP120 PDCL3 TUBGCP3 YLPM1 IFFO2 SMARCC2 PRMT1 MTCL1 DYNC1H1 | 3.82e-05 | 1155 | 165 | 17 | 20360068 |
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 4.58e-05 | 15 | 165 | 3 | 8838678 | |
| Pubmed | HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. | 4.58e-05 | 15 | 165 | 3 | 18854243 | |
| Pubmed | 5.61e-05 | 16 | 165 | 3 | 19259974 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DNAH3 MYH9 NAA15 POLR1A MYO7A DSP UBA2 PRC1 LCP1 MDN1 SMARCC2 MACF1 HSPA4 DYNC1H1 | 5.64e-05 | 847 | 165 | 14 | 35235311 |
| Pubmed | KIF13B ELOA MYH9 SMARCA5 DSP SYNE1 PPP1R9A FAM47B LCP1 LMOD3 MDN1 YLPM1 XRN1 MAP7D2 SMARCC2 MACF1 CEP295 DNAH8 CFAP46 | 5.85e-05 | 1442 | 165 | 19 | 35575683 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SMARCA5 FOXO6 DSP FBXO11 SMARCAD1 PFKL CPS1 PRC1 KIF7 NCOR2 MDN1 SMARCC2 NAA40 DYNC1H1 | 6.39e-05 | 857 | 165 | 14 | 25609649 |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 16006513 | ||
| Interaction | CDC5L interactions | CWF19L2 MYH9 SMARCA5 DSP SYNE1 WWP2 SRP68 SMARCAD1 PFKL PRC1 SMC5 SDAD1 CCNF MDN1 SUPT5H TUBGCP3 YLPM1 SMARCC2 MACF1 PRMT1 MRPL40 NAA40 MTCL1 ZRANB1 DYNC1H1 WWC1 | 3.75e-09 | 855 | 160 | 26 | int:CDC5L |
| Interaction | DISC1 interactions | CWF19L2 VPS18 PDE4B SYNE1 RANBP9 SRP68 COLGALT2 PFKL SMC5 KIF7 MACF1 PRMT1 SPARCL1 ZRANB1 GPANK1 DYNC1H1 | 3.32e-07 | 429 | 160 | 16 | int:DISC1 |
| Interaction | PPP2R2A interactions | MYH9 NRDC DSP WWP2 TNS2 NOD2 CCNF PPP2R1B PPP2R2B PPP2R2C PRMT1 ZRANB1 EPHA1 | 8.76e-07 | 301 | 160 | 13 | int:PPP2R2A |
| Interaction | GNL3 interactions | CWF19L2 POLR1A WWP2 RANBP9 SRP68 PRC1 SMC5 SDAD1 ITFG1 CCNF PRMT1 NAA40 ZRANB1 EPHA1 | 1.48e-06 | 368 | 160 | 14 | int:GNL3 |
| Interaction | USP7 interactions | MYH9 SMARCA5 ZC3H12A DSP SYNE1 WWP2 RANBP9 SRP68 RFFL SMARCAD1 LCK C5orf47 WTAP USP21 CCNF MDN1 BRPF1 YLPM1 MAP7D2 SMARCC2 MACF1 PRMT1 PPIP5K1 SPARCL1 NAA40 DNAH5 ZRANB1 DYNC1H1 | 1.50e-06 | 1313 | 160 | 28 | int:USP7 |
| Interaction | CDC73 interactions | ELOA MYH9 DSP UBA2 SMC5 ITFG1 CCNF NEFH SUPT5H BRPF1 PRMT1 ZRANB1 HSPA4 WWC1 | 2.59e-06 | 386 | 160 | 14 | int:CDC73 |
| Interaction | MTDH interactions | NPR1 MYH9 DSP SYNE1 WWP2 RANBP9 SRP68 TNS2 SMC5 ITFG1 KCNH1 GLG1 PRMT1 NAA40 DNAH5 ZRANB1 | 2.81e-06 | 505 | 160 | 16 | int:MTDH |
| Interaction | MECP2 interactions | NES ELOA CWF19L2 MYH9 SMARCA5 DSP SYNE1 AGPAT2 SRP68 FBXO11 PRC1 SMC5 SDAD1 WTAP SUPT5H NKAPD1 TUBGCP3 YLPM1 FGD1 SMARCC2 MACF1 PRMT1 MRPL40 NAA40 ZRANB1 DYNC1H1 EPHA1 | 3.24e-06 | 1287 | 160 | 27 | int:MECP2 |
| Interaction | XRCC5 interactions | SMARCA5 NAA15 WWP2 SMARCAD1 LCK PRC1 SMC5 ITFG1 CCNF SUPT5H BRPF1 PRMT1 NAA40 ZRANB1 HSPA4 DYNC1H1 | 3.61e-06 | 515 | 160 | 16 | int:XRCC5 |
| Interaction | CLTA interactions | NES MYH9 POLR1A PTPN23 WDFY4 ITFG1 NOD2 CCNF PIK3R1 XRN1 MAP7D2 ZRANB1 HSPA4 | 4.77e-06 | 351 | 160 | 13 | int:CLTA |
| Interaction | YLPM1 interactions | 5.42e-06 | 160 | 160 | 9 | int:YLPM1 | |
| Interaction | SHTN1 interactions | 6.69e-06 | 124 | 160 | 8 | int:SHTN1 | |
| Interaction | JUP interactions | MYH9 DSP RANBP9 LCK PRC1 SMC5 CCNF PPP2R2B PIK3R1 PKD1 PRMT1 AFDN NAA40 ZRANB1 HSPA4 | 7.79e-06 | 485 | 160 | 15 | int:JUP |
| Interaction | WDR6 interactions | MYH9 POLR1A WWP2 TNS2 LCK SDAD1 ITFG1 CCNF PIK3R1 PIK3R2 AFDN ZRANB1 | 8.18e-06 | 314 | 160 | 12 | int:WDR6 |
| Interaction | YWHAQ interactions | KIF13B MYH9 PDE4B SPARC FOXO6 KIF26B PPFIBP1 WWP2 PFKL LCK CPS1 SMC5 WTAP CCNF PIK3R2 TUBGCP3 MACF1 PRMT1 AFDN NAA40 ZRANB1 HSPA4 DYNC1H1 WWC1 | 8.36e-06 | 1118 | 160 | 24 | int:YWHAQ |
| Interaction | CAPZA2 interactions | MYH9 PDE4B WWP2 PPP1R9A PRC1 LCP1 WTAP CCNF EXOC6B MACF1 AFDN NAA40 MTCL1 ZRANB1 | 8.92e-06 | 430 | 160 | 14 | int:CAPZA2 |
| Interaction | NSUN2 interactions | POLR1A NRDC WWP2 PRC1 SDAD1 ITFG1 CCNF PIK3R1 PRMT1 NAA40 ZRANB1 EPHA1 | 1.09e-05 | 323 | 160 | 12 | int:NSUN2 |
| Interaction | EXOSC10 interactions | 1.21e-05 | 223 | 160 | 10 | int:EXOSC10 | |
| Interaction | NOP56 interactions | ELOA CWF19L2 RANBP9 SRP68 TRIM64 PRC1 SMC5 SDAD1 CCNF SUPT5H NKAPD1 PRMT1 CEP295 NAA40 ZRANB1 EPHA1 | 1.29e-05 | 570 | 160 | 16 | int:NOP56 |
| Interaction | DYNLL1 interactions | MYH9 DSP PPFIBP1 SMC5 WTAP ITFG1 CCNF PPP2R1B PPP2R2B IFFO2 NAA40 MTCL1 ZRANB1 DYNC1H1 WWC1 | 1.41e-05 | 510 | 160 | 15 | int:DYNLL1 |
| Interaction | PRPF19 interactions | ELOA CWF19L2 WWP2 SMARCAD1 PRC1 SMC5 ITFG1 CCNF PIK3R1 TUBGCP3 PRMT1 NAA40 ZRANB1 DYNC1H1 | 1.48e-05 | 450 | 160 | 14 | int:PRPF19 |
| Interaction | PA2G4 interactions | WWP2 SRP68 PRC1 SMC5 ITFG1 PIK3R1 PRMT1 NAA40 ZRANB1 HSPA4 TARBP1 | 1.74e-05 | 284 | 160 | 11 | int:PA2G4 |
| Interaction | THRB interactions | 1.82e-05 | 186 | 160 | 9 | int:THRB | |
| Interaction | RRBP1 interactions | PATL2 DSP WWP2 SRP68 TRIM64 SMC5 CCNF CEP120 PRMT1 NAA40 DNAH5 ZRANB1 | 1.86e-05 | 341 | 160 | 12 | int:RRBP1 |
| Interaction | ACTL6A interactions | FOXO6 WWP2 UBA2 SMARCAD1 WDFY4 KIF7 ITFG1 CCNF SMARCC2 PRMT1 ZRANB1 | 2.04e-05 | 289 | 160 | 11 | int:ACTL6A |
| Interaction | CCDC88C interactions | 2.13e-05 | 71 | 160 | 6 | int:CCDC88C | |
| Interaction | PPP2R1A interactions | MYH9 PPFIBP1 WWP2 PTPN23 TNS2 PRC1 ITFG1 NOD2 CCNF PPP2R1B PPP2R2B PPP2R2C SUPT5H PRMT1 MTCL1 ZRANB1 DYNC1H1 | 2.27e-05 | 665 | 160 | 17 | int:PPP2R1A |
| Interaction | TUBB interactions | SMARCA5 WWP2 PFKL LCK SMC5 WTAP ITFG1 CCNF MDN1 PIK3R2 TUBGCP3 PRMT1 CEP295 NAA40 ZRANB1 HSPA4 DYNC1H1 ADAP2 | 2.28e-05 | 735 | 160 | 18 | int:TUBB |
| Interaction | NDUFB10 interactions | 2.54e-05 | 194 | 160 | 9 | int:NDUFB10 | |
| Interaction | SNW1 interactions | CWF19L2 MYH9 SMARCA5 DSP SRP68 SMARCAD1 PFKL PRC1 SMC5 CCNF NCOR2 PPP2R1B MDN1 NKAPD1 TUBGCP3 PRMT1 NAA40 ZRANB1 | 2.82e-05 | 747 | 160 | 18 | int:SNW1 |
| Interaction | SSRP1 interactions | ELOA SMARCA5 ANKFY1 POLR1A WWP2 SMARCAD1 PRC1 SMC5 SDAD1 WTAP PPP2R1B SUPT5H PIK3R1 BRPF1 YLPM1 NAA40 ZRANB1 | 3.30e-05 | 685 | 160 | 17 | int:SSRP1 |
| Interaction | CCDC124 interactions | 3.52e-05 | 114 | 160 | 7 | int:CCDC124 | |
| Interaction | CRABP2 interactions | 3.65e-05 | 78 | 160 | 6 | int:CRABP2 | |
| Interaction | DDX17 interactions | WWP2 SMARCAD1 PRC1 SMC5 SDAD1 ITFG1 CCNF SUPT5H YLPM1 SMARCC2 PRMT1 NAA40 ZRANB1 | 3.70e-05 | 426 | 160 | 13 | int:DDX17 |
| Interaction | BICD2 interactions | VPS18 PTPN23 TNS2 PRC1 LCP1 KIF7 KLHL9 PDCL3 MAP7D2 AFDN DNAH5 ZRANB1 DYNC1H1 | 3.70e-05 | 426 | 160 | 13 | int:BICD2 |
| Interaction | KHDRBS1 interactions | DSCAM MYO7A WWP2 SMARCAD1 LCK PRC1 SMC5 ITFG1 PIK3R1 YLPM1 PRMT1 ZRANB1 | 4.47e-05 | 373 | 160 | 12 | int:KHDRBS1 |
| Interaction | YWHAG interactions | KIF13B SPARC NAA15 FOXO6 DSP KIF26B PPFIBP1 TNS2 PRC1 KIF7 USP21 CCNF MDN1 PIK3R1 SHPRH MACF1 PRMT1 PPIP5K1 AFDN MTCL1 ZRANB1 HSPA4 DYNC1H1 WWC1 | 4.99e-05 | 1248 | 160 | 24 | int:YWHAG |
| Interaction | EXOSC6 interactions | 5.16e-05 | 121 | 160 | 7 | int:EXOSC6 | |
| Interaction | ZC3H15 interactions | 5.44e-05 | 122 | 160 | 7 | int:ZC3H15 | |
| Interaction | RUVBL1 interactions | MYH9 SMARCA5 POLR1A WWP2 SMARCAD1 PRC1 SMC5 ITFG1 CCNF CCDC87 SMARCC2 PRMT1 NAA40 ZRANB1 HSPA4 | 5.61e-05 | 575 | 160 | 15 | int:RUVBL1 |
| Interaction | TUBG1 interactions | DSP RNF19A PTPN23 CPS1 ITFG1 PIK3R1 PDCL3 TUBGCP3 XRN1 CEP295 ZRANB1 HSPA4 | 5.63e-05 | 382 | 160 | 12 | int:TUBG1 |
| Interaction | PLRG1 interactions | 5.88e-05 | 216 | 160 | 9 | int:PLRG1 | |
| Interaction | H2BC9 interactions | MYH9 SMARCA5 DNAH10 DSP ABCA13 FAM47B LCK SMC5 KIF7 YLPM1 MAP7D2 SMARCC2 DNAH5 | 5.91e-05 | 446 | 160 | 13 | int:H2BC9 |
| Interaction | SPATA16 interactions | 6.26e-05 | 2 | 160 | 2 | int:SPATA16 | |
| Interaction | CTTN interactions | ELOA MYH9 NAA15 WWP2 PPP1R9A PRC1 SMC5 ITFG1 CCNF FGD1 PRMT1 NAA40 ZRANB1 | 6.46e-05 | 450 | 160 | 13 | int:CTTN |
| Interaction | NCL interactions | MYH9 SMARCA5 DSP WWP2 RANBP9 SRP68 PRC1 SMC5 ITGAV ITFG1 CCNF SUPT5H PIK3R1 PRMT1 NAA40 ZRANB1 HSPA4 ADAP2 | 6.63e-05 | 798 | 160 | 18 | int:NCL |
| Interaction | MARK2 interactions | KIF13B RANBP9 LCK USP21 PPP2R2B PKD1 AFDN MTCL1 ZRANB1 HSPA4 | 6.96e-05 | 274 | 160 | 10 | int:MARK2 |
| Interaction | CCDC8 interactions | SMARCA5 POLR1A DSP MROH2A PPP1R9A PFKL LCK KIF7 CCNF MDN1 SMARCC2 MACF1 AFDN ZRANB1 HSPA4 DYNC1H1 | 6.98e-05 | 656 | 160 | 16 | int:CCDC8 |
| Interaction | CPSF2 interactions | 7.39e-05 | 173 | 160 | 8 | int:CPSF2 | |
| Interaction | EFTUD2 interactions | CWF19L2 MYH9 SMARCA5 NAA15 DSP PPFIBP1 WWP2 RANBP9 SRP68 SMARCAD1 PFKL CPS1 PRC1 SMC5 ITFG1 CCNF SUPT5H SMARCC2 MACF1 PRMT1 NAA40 MTCL1 ADI1 ZRANB1 HSPA4 DYNC1H1 | 7.45e-05 | 1449 | 160 | 26 | int:EFTUD2 |
| Interaction | IQGAP1 interactions | VPS18 MYH9 NRDC DSCAM WWP2 UBA2 PRC1 WDFY4 CCNF PPP2R2B PPP2R2C PIK3R2 TUBGCP3 ZRANB1 DYNC1H1 | 7.63e-05 | 591 | 160 | 15 | int:IQGAP1 |
| Interaction | PDCD4 interactions | 8.34e-05 | 176 | 160 | 8 | int:PDCD4 | |
| Interaction | SIRT7 interactions | NES MYH9 NAA15 POLR1A DSP SRP68 LCP1 MDN1 SUPT5H YLPM1 XRN1 SMARCC2 MACF1 AFDN ZRANB1 HSPA4 DYNC1H1 | 9.14e-05 | 744 | 160 | 17 | int:SIRT7 |
| Interaction | CDCA8 interactions | 9.39e-05 | 133 | 160 | 7 | int:CDCA8 | |
| Interaction | RPL34 interactions | 9.64e-05 | 285 | 160 | 10 | int:RPL34 | |
| Interaction | NUMA1 interactions | SMARCA5 NAA15 WWP2 RANBP9 SMARCAD1 PRC1 SMC5 CCNF BRPF1 MACF1 NAA40 ZRANB1 DYNC1H1 | 9.79e-05 | 469 | 160 | 13 | int:NUMA1 |
| Interaction | GAR1 interactions | 1.02e-04 | 232 | 160 | 9 | int:GAR1 | |
| Interaction | DNAH5 interactions | 1.02e-04 | 31 | 160 | 4 | int:DNAH5 | |
| Interaction | ENKUR interactions | 1.03e-04 | 12 | 160 | 3 | int:ENKUR | |
| Interaction | USP11 interactions | MYH9 POLR1A DSCAM RANBP9 PTPN23 LCK LCP1 CCNF PPP2R1B PIK3R2 PRMT1 ZRANB1 HSPA4 DYNC1H1 | 1.05e-04 | 539 | 160 | 14 | int:USP11 |
| Interaction | SMC3 interactions | SMARCA5 POLR1A SMARCAD1 SMC5 CCNF MDN1 SUPT5H FGD1 PRMT1 ZRANB1 DYNC1H1 EPHA1 | 1.05e-04 | 408 | 160 | 12 | int:SMC3 |
| Interaction | RPS29 interactions | 1.05e-04 | 182 | 160 | 8 | int:RPS29 | |
| Interaction | DCAF11 interactions | 1.08e-04 | 136 | 160 | 7 | int:DCAF11 | |
| Interaction | KIF5B interactions | MYH9 SRP68 PTPN23 RFFL CCNF PIK3R1 MAP7D2 PRMT1 NAA40 ZRANB1 DYNC1H1 | 1.09e-04 | 348 | 160 | 11 | int:KIF5B |
| Interaction | IRS4 interactions | 1.11e-04 | 290 | 160 | 10 | int:IRS4 | |
| Interaction | CBS interactions | 1.13e-04 | 137 | 160 | 7 | int:CBS | |
| Interaction | HNRNPUL1 interactions | WWP2 RANBP9 PFKL PRC1 SMC5 ITFG1 CCNF PRMT2 PRMT1 NAA40 ZRANB1 | 1.18e-04 | 351 | 160 | 11 | int:HNRNPUL1 |
| Interaction | DDX23 interactions | ELOA CWF19L2 SYNE1 PFKL PRC1 WDFY4 SDAD1 CCNF SUPT5H NKAPD1 BRPF1 PRMT1 ZRANB1 | 1.23e-04 | 480 | 160 | 13 | int:DDX23 |
| Interaction | DBN1 interactions | MYH9 PPP1R9A RANBP9 PRC1 SMC5 CCNF PPP2R2B SUPT5H PRMT1 AFDN NAA40 ZRANB1 | 1.29e-04 | 417 | 160 | 12 | int:DBN1 |
| Interaction | C9orf78 interactions | ELOA SMARCA5 NRDC VPS50 RANBP9 UBA2 SDAD1 CEP120 SUPT5H GLG1 NKAPD1 TUBGCP3 AFDN ZRANB1 DYNC1H1 | 1.30e-04 | 620 | 160 | 15 | int:C9orf78 |
| Interaction | IER5 interactions | 1.32e-04 | 13 | 160 | 3 | int:IER5 | |
| Interaction | RBM14 interactions | SMARCA5 NAA15 WWP2 RANBP9 PRC1 SMC5 KIF7 ITFG1 CCNF YLPM1 SMARCC2 MACF1 PRMT1 ZRANB1 | 1.37e-04 | 553 | 160 | 14 | int:RBM14 |
| Interaction | FLII interactions | 1.39e-04 | 298 | 160 | 10 | int:FLII | |
| Interaction | PPP4C interactions | 1.41e-04 | 142 | 160 | 7 | int:PPP4C | |
| Interaction | CSNK2B interactions | CWF19L2 SMARCA5 DSCAM LCK SMC5 ITFG1 CCNF PPP2R1B SUPT5H NKAPD1 BRPF1 PRMT1 NAA40 ZRANB1 DYNC1H1 | 1.41e-04 | 625 | 160 | 15 | int:CSNK2B |
| Interaction | NEFM interactions | 1.42e-04 | 190 | 160 | 8 | int:NEFM | |
| Interaction | YWHAE interactions | KIF13B ELOA KIF26B PPFIBP1 WWP2 TNS2 PRC1 SMC5 WTAP ITFG1 USP21 CCNF NCOR2 PIK3R1 PIK3R2 SMARCC2 MACF1 PRMT1 AFDN ZRANB1 HSPA4 DYNC1H1 WWC1 | 1.51e-04 | 1256 | 160 | 23 | int:YWHAE |
| Interaction | PABPN1 interactions | 1.52e-04 | 192 | 160 | 8 | int:PABPN1 | |
| Interaction | ERH interactions | 1.54e-04 | 245 | 160 | 9 | int:ERH | |
| Interaction | PKP1 interactions | 1.54e-04 | 144 | 160 | 7 | int:PKP1 | |
| Interaction | TUBB4B interactions | MYH9 SMARCA5 LCK PRC1 SMC5 ITFG1 CCNF SCG2 TUBGCP3 PRMT1 NAA40 ZRANB1 DYNC1H1 ENOX2 | 1.56e-04 | 560 | 160 | 14 | int:TUBB4B |
| Interaction | TCP1 interactions | ELOA POLR1A LCK WDFY4 ITFG1 NOD2 CCNF PPP2R2B PPP2R2C PDCL3 PRMT1 NAA40 ZRANB1 HSPA4 | 1.59e-04 | 561 | 160 | 14 | int:TCP1 |
| Interaction | CYFIP1 interactions | 1.59e-04 | 303 | 160 | 10 | int:CYFIP1 | |
| Interaction | EPB41 interactions | 1.61e-04 | 145 | 160 | 7 | int:EPB41 | |
| Interaction | RCOR1 interactions | MYH9 SMARCA5 ANKFY1 DSP VPS50 RANBP9 ITFG1 NCOR2 XRN1 SMARCC2 PRMT1 ZRANB1 HSPA4 | 1.64e-04 | 494 | 160 | 13 | int:RCOR1 |
| Interaction | HNRNPC interactions | CWF19L2 SMARCA5 DSP WWP2 PRC1 SMC5 F8 ITFG1 CCNF SUPT5H NKAPD1 SMARCC2 PRMT1 MRPL40 ZRANB1 | 1.65e-04 | 634 | 160 | 15 | int:HNRNPC |
| Interaction | LIMA1 interactions | KIF13B MYH9 PPP1R9A RANBP9 PRC1 WDFY4 USP21 CCNF PRMT1 AFDN NAA40 ZRANB1 | 1.68e-04 | 429 | 160 | 12 | int:LIMA1 |
| Interaction | RPRD2 interactions | 1.68e-04 | 146 | 160 | 7 | int:RPRD2 | |
| Interaction | DCTN1 interactions | ANKFY1 NAA15 VPS50 RANBP9 PRC1 KIF7 NOD2 MAP7D2 MACF1 NAA40 ZRANB1 DYNC1H1 WWC1 | 1.74e-04 | 497 | 160 | 13 | int:DCTN1 |
| Interaction | RBM28 interactions | POLR1A WWP2 RANBP9 SRP68 PRC1 SMC5 SDAD1 CCNF PRMT1 ZRANB1 EPHA1 | 1.78e-04 | 368 | 160 | 11 | int:RBM28 |
| Interaction | HSPD1 interactions | MYH9 PDE4B NRDC DNAH10 RANBP9 TNS2 PFKL LCK PRC1 SMC5 ITFG1 CCNF PPP2R1B PPP2R2C TUBGCP3 PRMT1 NAA40 NME6 ZRANB1 HSPA4 | 1.78e-04 | 1022 | 160 | 20 | int:HSPD1 |
| Interaction | CD3E interactions | 1.79e-04 | 66 | 160 | 5 | int:CD3E | |
| Interaction | KHSRP interactions | 1.82e-04 | 308 | 160 | 10 | int:KHSRP | |
| Interaction | POLR2E interactions | ELOA SMARCA5 POLR1A WWP2 ITFG1 CCNF PPP2R1B SUPT5H PRMT1 ZRANB1 | 1.82e-04 | 308 | 160 | 10 | int:POLR2E |
| Interaction | HDAC2 interactions | ELOA MYH9 SMARCA5 WWP2 RANBP9 SMARCAD1 PFKL CPS1 PRC1 SMC5 CCNF NCOR2 TUBGCP3 SMARCC2 PRMT1 ZRANB1 HSPA4 DYNC1H1 | 1.82e-04 | 865 | 160 | 18 | int:HDAC2 |
| Interaction | AXL interactions | SMARCA5 DSP RANBP9 TNS2 PFKL LCK KCNE4 MDN1 PIK3R1 PIK3R2 DYNC1H1 | 1.82e-04 | 369 | 160 | 11 | int:AXL |
| Interaction | EED interactions | VPS18 MYH9 SMARCA5 ANKFY1 NAA15 DSP NDST4 UBA2 SRP68 FBXO11 SMARCAD1 PFKL SMC5 WTAP USP21 SUPT5H TUBGCP3 YLPM1 SHPRH SMARCC2 MACF1 AFDN NAA40 ZRANB1 DYNC1H1 | 1.84e-04 | 1445 | 160 | 25 | int:EED |
| Interaction | CHRNA2 interactions | 1.87e-04 | 3 | 160 | 2 | int:CHRNA2 | |
| Interaction | PATL2 interactions | 1.87e-04 | 3 | 160 | 2 | int:PATL2 | |
| Interaction | SRSF1 interactions | TRAF3IP2 SMARCA5 WWP2 RANBP9 SRP68 SMARCAD1 PRC1 SMC5 CCNF PIK3R1 NKAPD1 PRMT1 ZRANB1 DYNC1H1 | 1.87e-04 | 570 | 160 | 14 | int:SRSF1 |
| GeneFamily | Dyneins, axonemal | 3.35e-06 | 17 | 114 | 4 | 536 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.29e-04 | 16 | 114 | 3 | 173 | |
| GeneFamily | ATP binding cassette subfamily D | 2.35e-04 | 4 | 114 | 2 | 808 | |
| GeneFamily | C2 and WW domain containing | 2.35e-04 | 4 | 114 | 2 | 838 | |
| GeneFamily | Intermediate filaments Type IV | 5.81e-04 | 6 | 114 | 2 | 611 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.08e-03 | 8 | 114 | 2 | 939 | |
| GeneFamily | SPARC family | 1.08e-03 | 8 | 114 | 2 | 1278 | |
| GeneFamily | Protein arginine methyltransferases | 1.38e-03 | 9 | 114 | 2 | 691 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 2.50e-03 | 12 | 114 | 2 | 660 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.04e-03 | 46 | 114 | 3 | 622 | |
| GeneFamily | ATP binding cassette subfamily A | 3.41e-03 | 14 | 114 | 2 | 805 | |
| GeneFamily | SH2 domain containing | 3.83e-03 | 101 | 114 | 4 | 741 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.92e-03 | 15 | 114 | 2 | 696 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.55e-03 | 53 | 114 | 3 | 532 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 6.28e-03 | 19 | 114 | 2 | 563 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-08 | 190 | 165 | 9 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-08 | 193 | 165 | 9 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-08 | 193 | 165 | 9 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-08 | 193 | 165 | 9 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-07 | 162 | 165 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.65e-07 | 185 | 165 | 8 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-07 | 193 | 165 | 8 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.66e-07 | 194 | 165 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 7.19e-07 | 196 | 165 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 7.19e-07 | 196 | 165 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.19e-07 | 196 | 165 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-07 | 197 | 165 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-07 | 197 | 165 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-07 | 197 | 165 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-07 | 197 | 165 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 7.47e-07 | 197 | 165 | 8 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Biopsy_IPF-Endothelial-Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 8.37e-07 | 200 | 165 | 8 | 39b4faad5700b3108f851f0df7fea3d298514465 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 8.37e-07 | 200 | 165 | 8 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.50e-07 | 138 | 165 | 7 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.56e-06 | 151 | 165 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-06 | 151 | 165 | 7 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-06 | 151 | 165 | 7 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-06 | 154 | 165 | 7 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-06 | 166 | 165 | 7 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-06 | 169 | 165 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|metastatic_Brain / Location, Cell class and cell subclass | 4.14e-06 | 175 | 165 | 7 | b732c6a423c28856211002107d8c611dcfb6f265 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.30e-06 | 176 | 165 | 7 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-06 | 180 | 165 | 7 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-06 | 180 | 165 | 7 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 5.35e-06 | 182 | 165 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.55e-06 | 183 | 165 | 7 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 5.55e-06 | 183 | 165 | 7 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 184 | 165 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-06 | 184 | 165 | 7 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 184 | 165 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 184 | 165 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-06 | 184 | 165 | 7 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 5.96e-06 | 185 | 165 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.86e-06 | 189 | 165 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.10e-06 | 190 | 165 | 7 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-06 | 190 | 165 | 7 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-06 | 192 | 165 | 7 | 39afea574725ce0c67afdd79facdb34f819a828d | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-06 | 192 | 165 | 7 | 597db951b1fbc37db22134c3d27d3ec4ceaa85f7 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 7.60e-06 | 192 | 165 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.60e-06 | 192 | 165 | 7 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-06 | 192 | 165 | 7 | bc275a9eccb1c7a46fd58b15ca5acdd9f7495842 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.60e-06 | 192 | 165 | 7 | e4dd24aefdf13cd4206714f02fde2288f3173ffc | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.60e-06 | 192 | 165 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.86e-06 | 193 | 165 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.86e-06 | 193 | 165 | 7 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.13e-06 | 194 | 165 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.13e-06 | 194 | 165 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 8.13e-06 | 194 | 165 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.13e-06 | 194 | 165 | 7 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.41e-06 | 195 | 165 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.41e-06 | 195 | 165 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.41e-06 | 195 | 165 | 7 | 730c613cf6f4d16ca51fd44de1f5a883f615c5c5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-06 | 195 | 165 | 7 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 8.41e-06 | 195 | 165 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-06 | 195 | 165 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-06 | 195 | 165 | 7 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-06 | 195 | 165 | 7 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.69e-06 | 196 | 165 | 7 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.69e-06 | 196 | 165 | 7 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.69e-06 | 196 | 165 | 7 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 8.69e-06 | 196 | 165 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.69e-06 | 196 | 165 | 7 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.98e-06 | 197 | 165 | 7 | b5b333e98753946793ceb45e2d85c25ef53568b4 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.98e-06 | 197 | 165 | 7 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.98e-06 | 197 | 165 | 7 | 4cec48e202f4583c9328d4b722c49ed3471ec173 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 9.28e-06 | 198 | 165 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.28e-06 | 198 | 165 | 7 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 165 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-06 | 200 | 165 | 7 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.91e-06 | 200 | 165 | 7 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 165 | 7 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.91e-06 | 200 | 165 | 7 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.91e-06 | 200 | 165 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 9.91e-06 | 200 | 165 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-06 | 200 | 165 | 7 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 85 | 165 | 5 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 85 | 165 | 5 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 145 | 165 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 148 | 165 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 148 | 165 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 154 | 165 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 154 | 165 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 154 | 165 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 154 | 165 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 155 | 165 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 155 | 165 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.47e-05 | 155 | 165 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.85e-05 | 159 | 165 | 6 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.85e-05 | 159 | 165 | 6 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.17e-05 | 162 | 165 | 6 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.75e-05 | 167 | 165 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 169 | 165 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.28e-05 | 171 | 165 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-05 | 174 | 165 | 6 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 175 | 165 | 6 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| Drug | Biliton | 4.33e-07 | 41 | 162 | 6 | CID000002974 | |
| Drug | Argentine | 3.46e-06 | 33 | 162 | 5 | CID000442941 | |
| Drug | cnicin | 4.28e-06 | 92 | 162 | 7 | CID000091176 | |
| Drug | decamethonium | 6.96e-06 | 6 | 162 | 3 | ctd:C033019 | |
| Drug | carbaryl | 7.55e-06 | 66 | 162 | 6 | CID000006129 | |
| Drug | 3-isoreserpine | 9.16e-06 | 190 | 162 | 9 | CID000005052 | |
| Drug | phenoxyethylpenicillin | 1.93e-05 | 8 | 162 | 3 | CID000004758 | |
| Drug | Dimethylphenylpiperazinium Iodide | 1.93e-05 | 8 | 162 | 3 | ctd:D004246 | |
| Drug | epibatidine | 1.93e-05 | 8 | 162 | 3 | ctd:C082748 | |
| Drug | Skpymrfamide | 1.97e-05 | 23 | 162 | 4 | CID000132661 | |
| Disease | Bipolar Disorder | PDE4B DSCAM ABCA13 WFS1 SYNE1 PFKL ADCY3 CHRNA2 NOD2 PPP2R2C DNAH8 HSPA4 | 1.23e-05 | 477 | 160 | 12 | C0005586 |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 8.32e-05 | 16 | 160 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.46e-04 | 49 | 160 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | glycine measurement, amino acid measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0005134, EFO_0009767 | |
| Disease | Autosomal dominant nocturnal frontal lobe epilepsy | 1.74e-04 | 4 | 160 | 2 | cv:C3696898 | |
| Disease | cerebellar cortex volume measurement | 1.94e-04 | 21 | 160 | 3 | EFO_0010291 | |
| Disease | Ciliopathies | 3.41e-04 | 110 | 160 | 5 | C4277690 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 5.15e-04 | 29 | 160 | 3 | cv:C5779548 | |
| Disease | waist circumference | DNAH10 WWP2 PPP1R9A SMARCAD1 ADCY3 KCNE4 CEP120 RESP18 DNAH5 | 5.83e-04 | 429 | 160 | 9 | EFO_0004342 |
| Disease | dipeptidyl peptidase 2 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0020326 | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 6.03e-04 | 7 | 160 | 2 | C3696898 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 7.58e-04 | 33 | 160 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | Moderate albuminuria, diabetic nephropathy | 8.01e-04 | 8 | 160 | 2 | EFO_0000401, HP_0012594 | |
| Disease | metabolite measurement | 1.01e-03 | 560 | 160 | 10 | EFO_0004725 | |
| Disease | breast cancer, ovarian carcinoma | 1.06e-03 | 37 | 160 | 3 | EFO_0001075, MONDO_0007254 | |
| Disease | kidney disease (implicated_via_orthology) | 1.43e-03 | 41 | 160 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | body fat percentage | 1.44e-03 | 488 | 160 | 9 | EFO_0007800 | |
| Disease | nucleus accumbens volume change measurement | 1.56e-03 | 11 | 160 | 2 | EFO_0021493 | |
| Disease | Colorectal Carcinoma | DNAH3 VPS18 SPARC ABCA13 SYNE1 ZNF442 PPP2R1B ABCD4 ABCD2 DNAH8 EPHA1 | 1.62e-03 | 702 | 160 | 11 | C0009402 |
| Disease | smoking status measurement | PDE4B POLR1A FOXO6 WWP2 FBXO11 ADCY3 CHRNA2 PPP2R2C GALNT17 SPATA16 XRN1 CEP295 IGSF9B AGBL2 DNAH8 | 1.67e-03 | 1160 | 160 | 15 | EFO_0006527 |
| Disease | endometrial carcinoma (is_implicated_in) | 1.86e-03 | 12 | 160 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.86e-03 | 12 | 160 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Tobacco Dependence | 2.55e-03 | 14 | 160 | 2 | C0040332 | |
| Disease | Nicotine Dependence | 2.55e-03 | 14 | 160 | 2 | C0028043 | |
| Disease | Arthritis, Psoriatic | 2.55e-03 | 14 | 160 | 2 | C0003872 | |
| Disease | Nicotine Use Disorder | 2.55e-03 | 14 | 160 | 2 | C0376384 | |
| Disease | visceral:abdominal adipose tissue ratio measurement | 2.85e-03 | 52 | 160 | 3 | EFO_0803318 | |
| Disease | sexual dimorphism measurement | FOXO6 DNAH10 PTPN23 COLGALT2 LCK LCP1 ADCY3 NCOR2 CEP120 PIK3R1 EDEM2 PKD1 MACF1 ADAP2 | 2.88e-03 | 1106 | 160 | 14 | EFO_0021796 |
| Disease | Intellectual Disability | 3.15e-03 | 447 | 160 | 8 | C3714756 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 3.34e-03 | 16 | 160 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | nervousness | 3.34e-03 | 16 | 160 | 2 | NCIT_C74532 | |
| Disease | Drug habituation | 3.61e-03 | 115 | 160 | 4 | C0013170 | |
| Disease | Drug abuse | 3.61e-03 | 115 | 160 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.61e-03 | 115 | 160 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.61e-03 | 115 | 160 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.61e-03 | 115 | 160 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.61e-03 | 115 | 160 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.61e-03 | 115 | 160 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.61e-03 | 115 | 160 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.61e-03 | 115 | 160 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.72e-03 | 116 | 160 | 4 | C0740858 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.77e-03 | 17 | 160 | 2 | C2936862 | |
| Disease | renal fibrosis (implicated_via_orthology) | 3.77e-03 | 17 | 160 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 40:6 measurement | 3.77e-03 | 17 | 160 | 2 | EFO_0010389 | |
| Disease | breast carcinoma | RNF19A RANBP9 PRC1 ADCY3 PPP2R1B CEP120 GLG1 PIK3R1 CCDC87 MRPL40 MTCL1 BBOX1 HSPA4 | 3.79e-03 | 1019 | 160 | 13 | EFO_0000305 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.83e-03 | 364 | 160 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Polydactyly | 3.84e-03 | 117 | 160 | 4 | C0152427 | |
| Disease | forced expiratory volume | DSCAM SYNE1 WWP2 ADCY3 CHRNA3 CHRNB2 NCOR2 CEP120 ANKDD1A MTCL1 HSPA4 | 3.96e-03 | 789 | 160 | 11 | EFO_0004314 |
| Disease | Colorectal Neoplasms | 4.13e-03 | 277 | 160 | 6 | C0009404 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 4.22e-03 | 18 | 160 | 2 | EFO_1000649, HP_0000131 | |
| Disease | phosphatidylcholine measurement | 4.65e-03 | 284 | 160 | 6 | EFO_0010226 | |
| Disease | cleft lip | 4.65e-03 | 284 | 160 | 6 | EFO_0003959 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 4.79e-03 | 200 | 160 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | ulcerative colitis, Crohn's disease | 5.21e-03 | 20 | 160 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | citrulline measurement | 5.21e-03 | 20 | 160 | 2 | EFO_0009777 | |
| Disease | age at menarche | 5.27e-03 | 594 | 160 | 9 | EFO_0004703 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQAAEDKSWRVRYMV | 261 | P30154 | |
| DAKWRVRLAIIEYMP | 426 | P30154 | |
| AEESDRLRKLMLEWQ | 1551 | P55196 | |
| RTVSEWLESIRMKRY | 916 | P21709 | |
| IMTRDYLTVKVWDLN | 296 | Q00005 | |
| MLTRDYLTVKVWDLN | 296 | Q9Y2T4 | |
| IWTDMKRVKEYSQRL | 361 | Q86TW2 | |
| GLRIRDMYVSWLDKN | 386 | Q6P093 | |
| FMIESILYARDAWLK | 221 | P55345 | |
| QRKRKEYWDMALSVD | 21 | Q13939 | |
| DDWKYVAMVIDRIFL | 466 | P32297 | |
| LADQMNLILSKRLWY | 326 | Q9UBJ2 | |
| NLILSKRLWYIMIEQ | 331 | Q9UBJ2 | |
| KEWRAELMLELLECY | 171 | Q8IYW2 | |
| EDWKYVAMVIDRIFL | 491 | Q15822 | |
| SKRYLWQTIMKEVRE | 4891 | Q86UQ4 | |
| RELMSKELWLYIGIN | 261 | O14678 | |
| LDWMFRYSLTNDIVK | 631 | P16066 | |
| SDKVEMLYWLQQQRR | 811 | Q9NVE4 | |
| QWIRAKYERREFMAD | 111 | Q9NPF8 | |
| ESMLNTVLYARDKWL | 171 | Q99873 | |
| KLAIWLNDMENYRLE | 416 | Q9HCE9 | |
| YMREWRTKIQAQIDR | 341 | Q96S59 | |
| WKLADRSKIYMADLE | 291 | O00391 | |
| EEEHLYALRWKELEM | 991 | Q9Y4B5 | |
| LAEVRREWAKYMEVH | 491 | Q9H3S7 | |
| TMLRWIYTDELEFRE | 116 | Q9P2R3 | |
| RYDQLMEAWEKKVER | 301 | Q9Y618 | |
| LLLYKDEERLWGEAM | 121 | Q8WWG9 | |
| AMRKGYWIILDELNL | 1141 | Q9NU22 | |
| GRYLNTWLMETKDRR | 356 | Q3ZCV2 | |
| TLLWLEEIYAEMELK | 536 | Q9BXT6 | |
| LWQIDREMLNLYIEN | 586 | P34932 | |
| KRARLQYEKQMEERW | 81 | Q96T17 | |
| DRAWERDLRTYMNLE | 341 | O95872 | |
| VQWRREQEHMLKDYL | 86 | Q8IX03 | |
| YWEKASRRMLEEERV | 76 | Q0VAK6 | |
| RVMEWLRSVDLAEYA | 811 | Q86W92 | |
| LNLTLDYRMHEKLWV | 126 | Q9UN88 | |
| QRIAEVRAKYEWLMK | 2026 | Q2KJY2 | |
| VRAKYEWLMKELEAT | 2031 | Q2KJY2 | |
| LYEWECKQRMLAREE | 211 | Q16206 | |
| KMLEDLRRVYDQLTW | 391 | Q5BJE1 | |
| WEVEDLMREFYSLKR | 496 | Q9BV94 | |
| WQLMRRYTLNILEEI | 496 | P13796 | |
| DKFEMDLRNLWRDSI | 231 | Q9BX97 | |
| NRQLLSDWKMERLFD | 381 | A8MYZ0 | |
| IEMYRRRRLAEWKAT | 71 | Q9H2J4 | |
| KAMLWLSEKLREVYR | 681 | P17858 | |
| SLELYRQWTDRIMEE | 571 | Q07343 | |
| SWLRKSYLRMKEQAE | 231 | Q2TBE0 | |
| IFRNYLLKDQWEMEL | 3401 | Q96JB1 | |
| DMDEVEFLRIKYWDR | 516 | Q8NA70 | |
| DKRLTLSQIYDWMVR | 106 | A8MYZ6 | |
| YWLEVALERQRLEMD | 1136 | Q2M1P5 | |
| QMWELNRRLEAYLAR | 11 | P48681 | |
| RWLRLEDPRMDYAAK | 221 | Q9P2J3 | |
| ELRMYDERAQEWRSL | 316 | Q9P2J3 | |
| LIRMNYLKTWFVIDL | 286 | O95259 | |
| PEELYQLMRLCWKER | 466 | P06239 | |
| FLWRAKRMEYILTDI | 666 | Q96CW5 | |
| LVMAQDQRIRWYLLS | 1951 | P00451 | |
| TYERMFRWLVLRINK | 421 | P35579 | |
| NRAYIDELWEMALSK | 366 | Q9Y2D4 | |
| ILKYVSMDSWNRELL | 136 | Q9H3R1 | |
| IQLRKTRDQYLMWLT | 571 | P27986 | |
| EKREEMTDDRAWYLI | 96 | Q86UY6 | |
| ANMLERLKIYEEAWT | 271 | Q9BXJ9 | |
| LRFVYELLSWVEEMQ | 586 | Q9UPN3 | |
| VSRVLVYDLVMDRKW | 1471 | Q7Z442 | |
| RWDKRLLSVYEMLPA | 296 | Q96QZ0 | |
| DLMQLRKIRDQYLVW | 566 | O00459 | |
| LRNTKWEMAAQLREY | 371 | P12036 | |
| MFLQLLEIEEGWKYR | 311 | C9JE40 | |
| EEIIYKIMRLLWATS | 206 | Q5W5W9 | |
| RLNDRIEMWSYAAKV | 1111 | Q92896 | |
| LDYMVTKIPRWDLDR | 766 | P31327 | |
| WNRVYKVISRMLEEN | 141 | Q569G3 | |
| NDTMRYILIDWLVEV | 306 | P41002 | |
| MLRLKELWFAEFRDL | 351 | Q8TD57 | |
| EYSLEKNLDRMKLDW | 1001 | Q8TD57 | |
| SWREMYLRLQDAREQ | 651 | Q14241 | |
| RETLEYKAALELEMW | 646 | Q8N960 | |
| NDPILWKRLYMEVFE | 191 | Q86XK2 | |
| EAERKAVQAMWARLY | 21 | Q8WWM9 | |
| WLYDAKRRQDSLESM | 901 | P15924 | |
| LYHWRTEMKQEREPV | 141 | P06756 | |
| AICALREELEMYKQW | 61 | O60519 | |
| YADWDVVMSRLRILR | 366 | O75936 | |
| RNALRVAEVWMDDYK | 396 | Q6IS24 | |
| WFYSRLKSMAQEEIR | 1086 | Q9BZC7 | |
| WYTRNMIKRLLEERE | 536 | Q5U5Z8 | |
| DQKERVYEMRRWNEA | 876 | O60266 | |
| RRWEEELAKRMNLQT | 221 | Q5TF58 | |
| WEAAMKRYDERIDRV | 546 | Q14204 | |
| KLLRWVRRNYGDMDI | 871 | Q86Z14 | |
| KRQEYRSMKGLRWED | 191 | Q96LL9 | |
| MARDELILRWKQYEA | 21 | Q15007 | |
| LDWELIYIGRKRMQV | 461 | Q8IYK4 | |
| YKRSEMKEDWQRELE | 291 | Q9C0D2 | |
| LRMVWIISRHYNKDE | 371 | Q8IVF4 | |
| RLAVLDWNQRAMDLY | 126 | Q96F10 | |
| QEFRDLLLNDWRKEM | 3536 | Q8TE73 | |
| IYLRQRWMDQRLVFE | 86 | O00591 | |
| ELMWVYLRLTVSRDR | 81 | Q8IXS8 | |
| LGERMVRENLKVWIY | 156 | O15120 | |
| DYEMVELFLRRLRLW | 4126 | P98161 | |
| IIYGMRTKQLRERIW | 321 | Q8NH67 | |
| RTKQLRERIWSYLMH | 326 | Q8NH67 | |
| DMWELEIALLVRYLE | 616 | A6NES4 | |
| WEKEDRIINPEMARY | 821 | O60469 | |
| WSLEKLDNRLLDMRD | 751 | Q9NQT8 | |
| LDNRLLDMRDLYQEW | 756 | Q9NQT8 | |
| RARLQEEYWDLQDML | 626 | A6NKG5 | |
| WSLYKQQERKMERDT | 121 | Q9NQ50 | |
| EMDYRQWRKIATEDL | 541 | A5PLK6 | |
| LRMWYELDEESRRKY | 1121 | O95602 | |
| LREVLKEHEWMYTEA | 271 | Q9H4L7 | |
| QIRQWQRYREMAEKL | 7561 | Q8NF91 | |
| RDDLLYREMTRKPWL | 326 | Q17RQ9 | |
| WELMERVTRLYKDQK | 276 | Q8WZ73 | |
| YARERDRKLMQEKWL | 246 | Q96NG3 | |
| LLPELEKRMEEWDRY | 436 | P98174 | |
| YVAEQWEMHRLEKER | 431 | O43663 | |
| NRQYWDEDLLMKVLE | 581 | P13521 | |
| KLLHEYWMALRNRVS | 1336 | Q149N8 | |
| DDIRYLLTMDKLWRK | 261 | Q9UBT2 | |
| IKLYWQAMIEEAITR | 306 | Q9BXB7 | |
| IDYDRIKARMSLKDW | 311 | O00267 | |
| LDVMIELYRRNIWND | 181 | Q9NVU7 | |
| TLLLLEALEMYKDDW | 606 | Q8TAQ2 | |
| NRYLLLVLMDAERAW | 121 | Q9UHB9 | |
| MKFRSWTYDRTEIDL | 171 | P17787 | |
| DYIWLDIMNERRKTE | 221 | P55201 | |
| SLVDMIIKADRFYRW | 371 | Q495B1 | |
| RIRGIDIIKWMERYL | 446 | O43734 | |
| DIIKWMERYLRDKTV | 451 | O43734 | |
| WKIRELEKQMEDAYR | 31 | Q6ZUT1 | |
| YLTENDMERWIKEHR | 911 | Q96JG6 | |
| KEEYIMLLTDWRFTR | 701 | O00308 | |
| DDDRANLMWKRYLER | 351 | Q9UK80 | |
| NLMWKRYLEREDSKI | 356 | Q9UK80 | |
| WILKARALTEMVYID | 51 | Q8TAM2 | |
| WKRFIEERLLMYSFV | 256 | Q5D1E8 | |
| WLIRSLYEMQEERLA | 741 | Q9HC29 | |
| VLMEKYEEFMLRRWL | 196 | Q9NV58 | |
| RYIMEFRVAERWELL | 646 | Q9UPX0 | |
| LQYMDNIRWIREAAR | 486 | Q96N76 | |
| WDKDLRVSDKYLLAM | 411 | A6NKU9 | |
| RMRDWLKNVLVTLYE | 166 | P09486 | |
| RMRDWLKNILMQLYE | 526 | Q14515 | |
| RDVWRTYLDMNRFDL | 396 | Q9P253 | |
| TALWDMLERKFLEYQ | 41 | Q6ZS81 | |
| FKYDIERIIDDWILM | 271 | Q8IZH2 | |
| MRELLWRKEDCQRFY | 46 | O75414 | |
| VRLLILEYARWSMID | 816 | O43847 | |
| RKRDWEAIASRMEDY | 2066 | P49750 | |
| EWGMLDKRQKELYRD | 346 | O60290 | |
| DRSQKELYWDAMLEK | 216 | Q9NWS9 | |
| KSLYRDVMWETIRNL | 51 | Q9H7R0 | |
| LYWQITEGRKIMIRL | 921 | Q6UXY8 | |
| EEWELLDEMQRLLYR | 26 | Q6P9A1 | |
| LKFWENYILIMETLE | 326 | Q13395 | |
| EARRMFKVYWELTDL | 376 | Q8TB96 | |
| REKLIKEMDYLWEIN | 136 | A6NGJ6 | |
| REWYTRILMKDIDIL | 421 | O60264 | |
| DLIEMLEAKRPWVEY | 261 | Q8IY18 | |
| REKLIKEMDYLWEIN | 136 | A6NI03 | |
| LDPLMERRWDLDLTY | 121 | Q63HR2 | |
| LMLQRWSKLERDFRQ | 711 | Q6PFW1 | |
| QWRREQERMLKEYLI | 16 | Q9ULE0 | |
| VTQMVEKWLDRYRQI | 676 | Q9UGI0 | |
| DLERAVRKAALVMYW | 171 | O76024 | |
| ELEKIRRERNYSWMD | 51 | Q9BV57 | |
| AEYLWRLEAEKMRLA | 861 | Q13402 | |
| KERMLKLESYWIEAQ | 726 | Q9ULJ8 |